LMO1 and Nephroblastoma: Specifically, the LMO1 rs2168101 GT/TT genotypes were found to decrease the risk of developing Wilms tumor in the dominant model (adjusted OR = 0.74, 95% CI = 0.59–0.93, P = 0.009).